The trajectory of immune status and the risk assessment model of treatment effect and prognosis in senile patients

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200066656

Enrollment

Unknown

Registered

2022-12-13

Start date

2022-12-30

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection in the elderly

Interventions

Group of elderly infected patients:None

Group of young and middle-aged infected patients:None

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Informed consent was signed before the test, and fully aware of the test content, process and possible adverse reactions; Be able to complete the sample collection according to the study protocol requirements; Age of 18; Gender: male and female; Clinical diagnosis suggests the development of an infection.

Exclusion criteria

Exclusion criteria: Severe immune deficiency, autoimmune disease, or in the acute phase of autoimmune disease; End-stage disease patients; Subjects that other investigators judged unsuitable to attend.

Design outcomes

Primary

Measure	Time frame
T cell subsets;Cytokines;Immune globulin;	—

Countries

China

Contacts

Public ContactLiao Xue Lian

University of Sichuan, West China Hospital

736139854@qq.com+86 18980602202

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026